CalciMedica, Inc. (CALC)
2.17
-0.03
(-1.36%)
USD |
NASDAQ |
Sep 04, 16:00
2.23
+0.06
(+2.76%)
After-Hours: 20:00
CalciMedica Shareholders Equity (Quarterly) : 5.513M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.513M |
| March 31, 2026 | -1.104M |
| December 31, 2025 | -6.641M |
| September 30, 2025 | -0.268M |
| June 30, 2025 | 6.103M |
| March 31, 2025 | 10.89M |
| December 31, 2024 | 14.41M |
| September 30, 2024 | 9.03M |
| June 30, 2024 | 13.84M |
| March 31, 2024 | 17.25M |
| December 31, 2023 | 8.157M |
| September 30, 2023 | 12.16M |
| June 30, 2023 | 16.22M |
| March 31, 2023 | 22.02M |
| Date | Value |
|---|---|
| December 31, 2022 | -71.30M |
| September 30, 2022 | 41.60M |
| June 30, 2022 | 49.69M |
| March 31, 2022 | 56.26M |
| December 31, 2021 | 65.02M |
| September 30, 2021 | 72.14M |
| June 30, 2021 | 78.67M |
| March 31, 2021 | 84.56M |
| December 31, 2020 | 94.79M |
| September 30, 2020 | 90.63M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -102.95M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.50M |
| Total Liabilities (Quarterly) | 13.99M |
| Debt to Equity Ratio | 1.669 |
| Current Ratio | 5.577 |
| Net Debt Paydown Yield | -0.38% |